Lilly re-joined Oxford Science Enterprises in May 2015, having previously been a founding Principal.
Spanning capital and talent, Lilly is responsible for connecting people and projects in mutually beneficial ways to build further value across the portfolio.
Prior to her current role at OSE, she was a Partner at RT Ventures, where she backed and raised money for a number of UK and US technology companies, both public and private, including Oxford Nanopore (LON:ONT), E-Therapeutics (LOND:ETX) and 4D Pharma. Before this, Lilly worked at Mosaic Ventures, the early-stage VC firm, and Lansdowne Partners, the London-based investment fund.
Supported by the German Academic Scholarship Foundation, Lilly holds a BA in Philosophy, Politics and Economics from the University of Oxford.